CMV Vaccine

18-40 years old | Female

This vaccine (mRNA-1647) is designed to protect against cytomegalovirus (CMV) infection. This trial is for individuals who are CMV seronegative (never had CMV).

Eligibility

• Must be around at least 1 child under the age of 5 years old for at least 8 hours a week (on average)
• You can still receive other vaccines during this trial (COVID-19 boosters, flu shots, etc.)
• Must NOT be taking Prednisone or any antivirals (such as herpes medication)

Trial Duration

Up to 14 visits over ~30 months

Compensation

Participants are paid for diary compliance and for time and travel associated with completion of study visits